The FDA approved Hibsago (bepirovirsen; GSK), the first antisense oligonucleotide for chronic hepatitis B, for use with a nucleos (t)ide analogue in adults without cirrhosis, the agency announced ...

The FDA approved bepirovirsen, the first antisense oligonucleotide for chronic hepatitis B, offering a new treatment with functional cure potential. Bepirovirsen is specifically approved for patients ...

A 40-year-old Delhi woman with AMH of 0.07 ng/ml welcomed a healthy baby after four egg retrievals, embryo pooling and PGT-A.

In a blog post and accompanying YouTube video, AMD has just revealed that it is bringing its ML-powered upscaling technology, FSR 4.1, to the Xbox Series S and X consoles, to Radeon RX 6000-series ...

Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one NAD+ vial nationwide, citing a lack of assurance of sterility. A North Carolina outsourcing facility is pulling 22 vials of ...

Neha Bora and similar Maoists do not accept the Indian Constitution at all. Their objective is to attack constitutional institutions ...

From AI-powered mineral discovery to autonomous exploration platforms, a new generation of technology companies is tackling mining’s most urgent challenges — just […] ...

The FDA approved GSK's bepirovirsen for adults with chronic hepatitis B on nucleoside therapy, based on phase 3 trials showing 19% functional cure. The FDA has approved Hibsago (bepirovirsen), GSK’s ...

North Korean hackers are using a post-quantum cryptographic mechanism to secure malicious payload delivery in new operations that combine old and new malware.

Higher ultraprocessed food intake is associated with greater odds of vascular brain injury and adiposity, but not cognitive performance.

FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up ...